Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease
NCT ID: NCT01458158
Last Updated: 2015-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2011-10-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients
NCT00161369
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627
Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients.
NCT07266220
Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
NCT00558142
Optimalization of Nephroprotection Using N-Acetylcysteine
NCT00572663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic nephropathy
Diabetic nephropathy in patients with type 2 diabetes
No interventions assigned to this group
chronic glomerulonephritis
chronic glomerulonephritis in patients without diabetes mellitus
No interventions assigned to this group
controls
participants without diabetic nephropathy and chronic glomerulonephritis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetes mellitus type 2
Exclusion Criteria
50 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AHEPA University Hospital
OTHER
Aristotle University Of Thessaloniki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Grigorios G. DIMAS
Doctor/PhD Candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Grigorios G. Dimas, MD
Role: PRINCIPAL_INVESTIGATOR
AHEPA University Hospital,Medical School of Aristotle University of Thessaloniki
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AHEPA University Hospital, Medical School of Aristotle University of Thessaloniki
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31-8-2010
Identifier Type: OTHER
Identifier Source: secondary_id
A13749
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.